Publication Information

{'id': 'https://openalex.org/W4396591101', 'doi': 'https://doi.org/10.1158/1538-7445.sabcs23-po4-06-07', 'title': 'Abstract PO4-06-07: Efficacy and safety of futibatinib in patients with locally advanced/metastatic triple-negative breast cancer harboring FGFR2 gene amplification: final results from the phase 2, open-label FOENIX-MBC2 study', 'display_name': 'Abstract PO4-06-07: Efficacy and safety of futibatinib in patients with locally advanced/metastatic triple-negative breast cancer harboring FGFR2 gene amplification: final results from the phase 2, open-label FOENIX-MBC2 study', 'publication_year': 2024, 'publication_date': '2024-05-02', 'ids': {'openalex': 'https://openalex.org/W4396591101', 'doi': 'https://doi.org/10.1158/1538-7445.sabcs23-po4-06-07'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.sabcs23-po4-06-07', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5101481867', 'display_name': 'Antonio Giordano', 'orcid': 'https://orcid.org/0000-0002-7760-9717'}, 'institutions': [{'id': 'https://openalex.org/I4210117453', 'display_name': 'Dana-Farber Cancer Institute', 'ror': 'https://ror.org/02jzgtq86', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210117453']}, {'id': 'https://openalex.org/I136199984', 'display_name': 'Harvard University', 'ror': 'https://ror.org/03vek6s52', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I136199984']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Antonio Giordano', 'raw_affiliation_strings': ['1Dana Farber Cancer Institute, Harvard University, Boston, MA;'], 'affiliations': [{'raw_affiliation_string': '1Dana Farber Cancer Institute, Harvard University, Boston, MA;', 'institution_ids': ['https://openalex.org/I4210117453', 'https://openalex.org/I136199984']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5061962242', 'display_name': 'Nisha Unni', 'orcid': 'https://orcid.org/0000-0003-1549-4720'}, 'institutions': [{'id': 'https://openalex.org/I867280407', 'display_name': 'The University of Texas Southwestern Medical Center', 'ror': 'https://ror.org/05byvp690', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I867280407']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Nisha Unni', 'raw_affiliation_strings': ['2University of Texas Southwestern Medical Center, Dallas, Texas, United States;'], 'affiliations': [{'raw_affiliation_string': '2University of Texas Southwestern Medical Center, Dallas, Texas, United States;', 'institution_ids': ['https://openalex.org/I867280407']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5009582590', 'display_name': 'Senthil Damodaran', 'orcid': 'https://orcid.org/0000-0002-2470-0891'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Senthil Damodaran', 'raw_affiliation_strings': ['3The University of Texas MD Anderson Cancer Center, Houston, Texas, United States;'], 'affiliations': [{'raw_affiliation_string': '3The University of Texas MD Anderson Cancer Center, Houston, Texas, United States;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5002767668', 'display_name': 'Hope Rugo', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210167126', 'display_name': 'UCSF Helen Diller Family Comprehensive Cancer Center', 'ror': 'https://ror.org/05yndxy10', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I180670191', 'https://openalex.org/I4210110664', 'https://openalex.org/I4210167126']}, {'id': 'https://openalex.org/I180670191', 'display_name': 'University of California, San Francisco', 'ror': 'https://ror.org/043mz5j54', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I180670191']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Hope Rugo', 'raw_affiliation_strings': ['4Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States;'], 'affiliations': [{'raw_affiliation_string': '4Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States;', 'institution_ids': ['https://openalex.org/I4210167126', 'https://openalex.org/I180670191']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5054331333', 'display_name': 'Timothy Crook', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I172427033', 'display_name': 'Sarah Cannon Research Institute', 'ror': 'https://ror.org/03cp5cj42', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I172427033']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Timothy Crook', 'raw_affiliation_strings': ['5Sarah Cannon Research Institute, London, UK;'], 'affiliations': [{'raw_affiliation_string': '5Sarah Cannon Research Institute, London, UK;', 'institution_ids': ['https://openalex.org/I172427033']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5107343489', 'display_name': 'Thomas Bachelot', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210105738', 'display_name': 'Centre Léon Bérard', 'ror': 'https://ror.org/01cmnjq37', 'country_code': 'FR', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210105738']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Thomas Bachelot', 'raw_affiliation_strings': ['6Medical Oncology, Centre Léon Bérard, France;'], 'affiliations': [{'raw_affiliation_string': '6Medical Oncology, Centre Léon Bérard, France;', 'institution_ids': ['https://openalex.org/I4210105738']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5088488154', 'display_name': 'Federico Piacentini', 'orcid': 'https://orcid.org/0000-0001-8969-638X'}, 'institutions': [{'id': 'https://openalex.org/I122346577', 'display_name': 'University of Modena and Reggio Emilia', 'ror': 'https://ror.org/02d4c4y02', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I122346577']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Federico Piacentini', 'raw_affiliation_strings': ['7University of Modena and Reggio Emilia, MODENA, Emilia-Romagna, Italy;'], 'affiliations': [{'raw_affiliation_string': '7University of Modena and Reggio Emilia, MODENA, Emilia-Romagna, Italy;', 'institution_ids': ['https://openalex.org/I122346577']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5047170696', 'display_name': 'Héctor Soto Parrà', 'orcid': 'https://orcid.org/0000-0001-7966-4472'}, 'institutions': [{'id': 'https://openalex.org/I4210160210', 'display_name': 'Azienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele', 'ror': 'https://ror.org/051tt6c85', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210160210']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Hector Soto Parra', 'raw_affiliation_strings': ['8University Hospital Policlinico Vittorio Emanuele, Catania, Italy;'], 'affiliations': [{'raw_affiliation_string': '8University Hospital Policlinico Vittorio Emanuele, Catania, Italy;', 'institution_ids': ['https://openalex.org/I4210160210']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5032785430', 'display_name': 'Ian E. Krop', 'orcid': 'https://orcid.org/0000-0002-6380-5944'}, 'institutions': [{'id': 'https://openalex.org/I2802730090', 'display_name': 'Yale Cancer Center', 'ror': 'https://ror.org/03j7sze86', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I2802730090', 'https://openalex.org/I4210117499', 'https://openalex.org/I4210165192']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ian Krop', 'raw_affiliation_strings': ['9Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, United States;'], 'affiliations': [{'raw_affiliation_string': '9Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, United States;', 'institution_ids': ['https://openalex.org/I2802730090']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5029250198', 'display_name': 'Masashi Shimura', 'orcid': 'https://orcid.org/0000-0003-1233-4588'}, 'institutions': [{'id': 'https://openalex.org/I4210124059', 'display_name': 'Taiho Oncology (United States)', 'ror': 'https://ror.org/02z43nn16', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210124059']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Masashi Shimura', 'raw_affiliation_strings': ['10Taiho Oncology, Inc., Princeton, New Jersey, United States;'], 'affiliations': [{'raw_affiliation_string': '10Taiho Oncology, Inc., Princeton, New Jersey, United States;', 'institution_ids': ['https://openalex.org/I4210124059']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058426048', 'display_name': 'Gareth Tomlinson', 'orcid': 'https://orcid.org/0009-0002-7731-8829'}, 'institutions': [{'id': 'https://openalex.org/I4210124059', 'display_name': 'Taiho Oncology (United States)', 'ror': 'https://ror.org/02z43nn16', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210124059']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Gareth Tomlinson', 'raw_affiliation_strings': ['10Taiho Oncology, Inc., Princeton, New Jersey, United States;'], 'affiliations': [{'raw_affiliation_string': '10Taiho Oncology, Inc., Princeton, New Jersey, United States;', 'institution_ids': ['https://openalex.org/I4210124059']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5113839517', 'display_name': 'Maciej Gil', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210124059', 'display_name': 'Taiho Oncology (United States)', 'ror': 'https://ror.org/02z43nn16', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210124059']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Maciej Gil', 'raw_affiliation_strings': ['10Taiho Oncology, Inc., Princeton, New Jersey, United States;'], 'affiliations': [{'raw_affiliation_string': '10Taiho Oncology, Inc., Princeton, New Jersey, United States;', 'institution_ids': ['https://openalex.org/I4210124059']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5060044961', 'display_name': 'Nicholas C. Turner', 'orcid': 'https://orcid.org/0000-0001-8937-0873'}, 'institutions': [{'id': 'https://openalex.org/I4210121186', 'display_name': 'Royal Marsden Hospital', 'ror': 'https://ror.org/034vb5t35', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038', 'https://openalex.org/I4210121186']}, {'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Nicholas Turner', 'raw_affiliation_strings': ['11Royal Marsden Hospital, Institute of Cancer Research, London, England, United Kingdom;'], 'affiliations': [{'raw_affiliation_string': '11Royal Marsden Hospital, Institute of Cancer Research, London, England, United Kingdom;', 'institution_ids': ['https://openalex.org/I4210121186', 'https://openalex.org/I142947616']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5001814176', 'display_name': 'Fabrice André', 'orcid': 'https://orcid.org/0000-0001-5795-8357'}, 'institutions': [{'id': 'https://openalex.org/I2801843802', 'display_name': 'Institut Gustave Roussy', 'ror': 'https://ror.org/0321g0743', 'country_code': 'FR', 'type': 'facility', 'lineage': ['https://openalex.org/I2801843802']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Fabrice André', 'raw_affiliation_strings': ['12Faculté de Medicine Paris-Sud XI, Gustave Roussy, France'], 'affiliations': [{'raw_affiliation_string': '12Faculté de Medicine Paris-Sud XI, Gustave Roussy, France', 'institution_ids': ['https://openalex.org/I2801843802']}]}], 'institution_assertions': [], 'countries_distinct_count': 4, 'institutions_distinct_count': 15, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 84}, 'biblio': {'volume': '84', 'issue': '9_Supplement', 'first_page': 'PO4', 'last_page': '07'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12992', 'display_name': 'Metastasis and carcinoma case studies', 'score': 0.9931, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12992', 'display_name': 'Metastasis and carcinoma case studies', 'score': 0.9931, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12287', 'display_name': 'Fibroblast Growth Factor Research', 'score': 0.9914, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12379', 'display_name': 'Cancer Diagnosis and Treatment', 'score': 0.9885, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/triple-negative-breast-cancer', 'display_name': 'Triple-negative breast cancer', 'score': 0.77736974}, {'id': 'https://openalex.org/keywords/open-label', 'display_name': 'Open label', 'score': 0.6738149}], 'concepts': [{'id': 'https://openalex.org/C2780110267', 'wikidata': 'https://www.wikidata.org/wiki/Q7843332', 'display_name': 'Triple-negative breast cancer', 'level': 4, 'score': 0.77736974}, {'id': 'https://openalex.org/C2775930923', 'wikidata': 'https://www.wikidata.org/wiki/Q12859063', 'display_name': 'Metastatic breast cancer', 'level': 4, 'score': 0.6828175}, {'id': 'https://openalex.org/C3019800554', 'wikidata': 'https://www.wikidata.org/wiki/Q3813242', 'display_name': 'Open label', 'level': 3, 'score': 0.6738149}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.57797253}, {'id': 'https://openalex.org/C530470458', 'wikidata': 'https://www.wikidata.org/wiki/Q128581', 'display_name': 'Breast cancer', 'level': 3, 'score': 0.4849096}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.42459744}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.42386508}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.42208213}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.41386855}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.10567927}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.sabcs23-po4-06-07', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.85, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3203106735', 'https://openalex.org/W3200352014', 'https://openalex.org/W2989121736', 'https://openalex.org/W2955569507', 'https://openalex.org/W2892677547', 'https://openalex.org/W2581171191', 'https://openalex.org/W2077649377', 'https://openalex.org/W2037317309', 'https://openalex.org/W2001196910', 'https://openalex.org/W1999702412'], 'abstract_inverted_index': {'Abstract': [0], 'Background:': [1], 'Triple-negative': [2], 'breast': [3, 10, 33, 68, 470], 'cancer': [4, 471], '(TNBC)': [5], 'accounts': [6], 'for': [7, 61, 78, 119, 125], '~15%': [8], 'of': [9, 58, 83, 109, 132, 200, 229, 253, 319, 330, 349, 371, 462, 488], 'cancers': [11], 'and': [12, 35, 53, 75, 111, 179, 203, 279, 324, 359, 400, 460], 'represents': [13], 'an': [14, 29, 105, 363, 402], 'aggressive': [15], 'subtype': [16], 'with': [17, 66, 85, 99, 171, 211, 249, 302, 384, 407, 466], 'limited': [18], 'targeted': [19], 'therapeutic': [20], 'options.': [21], 'Fibroblast': [22], 'growth': [23], 'factor': [24], 'receptor': [25], '(FGFR)': [26], 'signaling': [27], 'plays': [28], 'important': [30], 'role': [31], 'in': [32, 64, 80, 169, 219, 271, 328, 340, 464], 'tumorigenesis': [34], 'metastasis.': [36], 'The': [37, 158], 'phase': [38, 480], '2': [39, 234], 'FOENIX-MBC2': [40, 483], 'study': [41, 484], '(NCT04024436)': [42], 'was': [43, 161, 269, 283, 333, 398], 'designed': [44], 'to': [45, 48, 366, 413], 'evaluate': [46], 'responses': [47], 'futibatinib,': [49], 'a': [50, 225, 237, 250, 303, 352], 'highly': [51], 'selective': [52], 'potent': [54], 'irreversible': [55], 'covalent': [56], 'inhibitor': [57], 'FGFR1–4': [59], '(FDA-approved': [60], 'intrahepatic': [62], 'cholangiocarcinoma),': [63], 'patients': [65, 84, 94, 170, 210, 235, 261, 273, 291, 350, 383, 415, 465], 'metastatic': [67, 385], 'cancer.': [69], 'Here,': [70], 'we': [71], 'report': [72], 'final': [73, 476], 'efficacy': [74], 'safety': [76, 404, 461], 'data': [77], 'futibatinib': [79, 142, 391, 421, 463], 'the': [81, 192, 280, 334, 372, 479, 489], 'cohort': [82], 'advanced/metastatic': [86, 97, 468], 'TNBC': [87, 98, 212, 386], 'harboring': [88, 387, 472], 'FGFR2': [89, 126, 174, 388, 473], 'gene': [90, 127, 389, 474], 'amplification.': [91, 175], 'Methods:': [92], 'Eligible': [93], 'had': [95, 223, 236, 262, 293, 351, 362, 401], 'locally': [96, 467], 'measurable': [100], 'disease': [101, 113, 148], 'per': [102], 'RECIST': [103, 167], 'v1.1,': [104], 'ECOG': [106], 'performance': [107], 'status': [108], '0/1,': [110], 'progressive': [112], 'after': [114, 184], '≥1': [115, 294], 'prior': [116, 230], 'chemotherapy-containing': [117], 'regimen': [118], 'advanced': [120], 'disease.': [121, 264], 'Patients': [122, 139, 222], 'were': [123, 156, 213, 376], 'positive': [124], 'amplification': [128], 'determined': [129], 'by': [130, 166], 'analysis': [131], 'tumor': [133, 137], 'tissue': [134], 'or': [135, 152, 310, 374], 'circulating': [136], 'DNA.': [138], 'received': [140, 224], 'oral': [141], '20': [143], 'mg': [144], 'once': [145], 'daily': [146], 'until': [147], 'progression,': [149], 'unacceptable': [150], 'toxicity,': [151], 'other': [153], 'discontinuation': [154], 'criteria': [155], 'met.': [157], 'primary': [159], 'endpoint': [160], 'objective': [162], 'response': [163, 178, 201, 240], 'rate': [164], '(ORR)': [165], 'v1.1': [168], 'centrally': [172], 'confirmed': [173, 238], 'Responses': [176], '(complete': [177], 'partial': [180, 239], 'response)': [181], 'required': [182], 'confirmation': [183], 'at': [185, 266], 'least': [186], '4': [187, 272, 309], 'weeks.': [188], 'Secondary': [189], 'endpoints': [190], 'included': [191, 316], '6-month': [193], 'progression-free': [194], 'survival': [195], '(PFS)': [196], 'rate,': [197], 'PFS,': [198], 'duration': [199], '(DOR),': [202], 'overall': [204], 'safety.': [205], 'Results:': [206], 'Overall,': [207, 233, 347], '21': [208], 'female': [209], 'enrolled': [214], '(median': [215], 'age:': [216], '53': [217], 'years)': [218], 'this': [220], 'cohort.': [221], 'median': [226, 251, 281], '5': [227], 'lines': [228], 'systemic': [231], 'therapy.': [232], '(ORR:': [241], '9.5%;': [242], '95%': [243, 275], 'confidence': [244], 'interval': [245], '[CI]:': [246], '1.2,': [247], '30.4),': [248], 'DOR': [252], '6.1': [254], 'months': [255, 268, 285], '(range:': [256], '3.1−9.2': [257], 'months).': [258], 'Five': [259], '(23.8%)': [260], 'stable': [263], 'PFS': [265, 282], '6': [267], 'observed': [270, 339], '(19.0%;': [274], 'CI:': [276, 287], '5.4,': [277], '41.9)': [278], '1.9': [284], '(95%': [286], '1.6,': [288], '4.0).': [289], 'Twenty': [290], '(95.2%)': [292], 'treatment-related': [295], 'adverse': [296, 354], 'event': [297, 355], '(TRAE),': [298], 'including': [299], '7': [300], '(33.3%)': [301], 'Grade': [304, 308, 336], '3': [305, 337], 'TRAE': [306, 338], '(no': [307], '5).': [311], 'Common': [312], 'TRAEs': [313], '(any': [314], 'grade)': [315], 'hyperphosphatemia': [317], '(85.7%': [318], 'patients),': [320], 'constipation,': [321], 'diarrhea,': [322], 'fatigue,': [323], 'dry': [325], 'skin': [326], '(each': [327], '23.8%': [329], 'patients).': [331], 'Anemia': [332], 'only': [335], 'more': [341], 'than': [342], '1': [343, 360], 'patient': [344, 361], '(n=2,': [345], '9.5%).': [346], '28.6%': [348], 'serious': [353], '(SAE;': [356], 'any': [357], 'cause),': [358], 'SAE': [364], 'leading': [365], 'death': [367], '(ischemic': [368], 'stroke).': [369], 'None': [370], 'SAEs': [373], 'deaths': [375], 'considered': [377], 'treatment-related.': [378], 'Conclusions:': [379], 'In': [380], 'heavily': [381], 'pretreated': [382], 'amplification,': [390], 'monotherapy': [392], 'demonstrated': [393], 'modest': [394], 'anticancer': [395], 'activity.': [396], 'Futibatinib': [397], 'tolerable': [399], 'acceptable': [403], 'profile,': [405], 'consistent': [406], 'previous': [408], 'data.': [409], 'Further': [410], 'biomarker': [411], 'work': [412], 'identify': [414], 'who': [416], 'might': [417], 'benefit': [418], 'most': [419], 'from': [420, 478], 'is': [422], 'ongoing.': [423], 'Clinical': [424], 'trial': [425], 'information:': [426], 'NCT04024436': [427], 'Citation': [428], 'Format:': [429], 'Antonio': [430, 492], 'Giordano,': [431], 'Nisha': [432], 'Unni,': [433], 'Senthil': [434], 'Damodaran,': [435], 'Hope': [436], 'Rugo,': [437], 'Timothy': [438], 'Crook,': [439], 'Thomas': [440], 'Bachelot,': [441], 'Federico': [442], 'Piacentini,': [443], 'Hector': [444], 'Soto': [445], 'Parra,': [446], 'Ian': [447], 'Krop,': [448], 'Masashi': [449], 'Shimura,': [450], 'Gareth': [451], 'Tomlinson,': [452], 'Maciej': [453], 'Gil,': [454], 'Nicholas': [455], 'Turner,': [456], 'Fabrice': [457], 'André.': [458], 'Efficacy': [459], 'triple-negative': [469], 'amplification:': [475], 'results': [477], '2,': [481], 'open-label': [482], '[abstract].': [485], 'In:': [486], 'Proceedings': [487], '2023': [490, 496], 'San': [491, 499], 'Breast': [493], 'Cancer': [494, 505], 'Symposium;': [495], 'Dec': [497], '5-9;': [498], 'Antonio,': [500], 'TX.': [501], 'Philadelphia': [502], '(PA):': [503], 'AACR;': [504], 'Res': [506], '2024;84(9': [507], 'Suppl):Abstract': [508], 'nr': [509], 'PO4-06-07.': [510]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4396591101', 'counts_by_year': [], 'updated_date': '2024-12-11T21:37:22.300662', 'created_date': '2024-05-03'}